SwePub
Sök i LIBRIS databas

  Extended search

L773:1872 7913
 

Search: L773:1872 7913 > Antimicrobial resis...

Antimicrobial resistance surveillance of Bacteroides fragilis isolated from blood cultures, Europe, 2022 (ReSuBacfrag)

Buhl, Michael E.J. (author)
Paracelsus Medical University
Sunnerhagen, Torgny (author)
Lund University,Lunds universitet,Infektionsmedicin,Sektion III,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Infection Medicine (BMC),Section III,Department of Clinical Sciences, Lund,Faculty of Medicine,Region Skåne
Join-Lambert, Olivier (author)
University Hospital Of Caen
show more...
Morris, Trefor (author)
University Hospital of Wales
Jeverica, Samo (author)
Slovenian National Laboratory of Health, Environment and Food
Assous, Marc V. (author)
Hebrew University of Jerusalem
Toprak, Nurver U. (author)
Marmara University Hospital
Alcalá-Hernandez, Luis (author)
Hospital Gregorio Maranon
Lienhard, Reto (author)
ADMed Microbiologie
Veloo, Alida C.M. (author)
University Medical Center Groningen
Cruz, Hugo (author)
S. António General Hospital
Sóki, József (author)
University of Szeged
Novak, Anita (author)
University Hospital of Split
Mazzariol, Annarita (author)
University of Verona
Wybo, Ingrid (author)
Vrije Universiteit Brussel (VUB)
Dumont, Yann (author)
University Hospital of Nancy
Justesen, Ulrik s. (author)
Odense University Hospital
show less...
 (creator_code:org_t)
 
English 17 s.
In: International Journal of Antimicrobial Agents. - 1872-7913.
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • BackgroundBacteroides fragilis is the most frequent cause of anaerobic bacteraemia. Although recent data suggest a rise in antimicrobial resistance (AMR) of this and other anaerobic bacteria, surveillance remains limited due to a lack of both data availability and comparability. However, a newly introduced standardised method for antimicrobial susceptibility testing (AST) of anaerobic bacteria has made larger scale surveillance possible for the first time.AimTo investigate phenotypic AMR of Bacteroides fragilis isolates from bacteraemia across Europe in 2022.MethodsIn a multicentre approach, clinical microbiology laboratories in Europe were invited to contribute results of AST for Bacteroides fragilis blood culture isolates (including only the first isolate per patient and year). AST of a selection of four antibiotics was performed locally by participating laboratories in a prospective or retrospective manner, using the new EUCAST disc diffusion method on fastidious anaerobe agar (FAA-HB).ResultsA total of 16 European countries reported antimicrobial susceptibilities in 449 unique isolates of Bacteroides fragilis from blood cultures in 2022. Clindamycin demonstrated the highest resistance rates (20.9%, range 0 - 63.6%), followed by piperacillin-tazobactam (11.1%, 0 - 54.5%), meropenem (13.4%, 0 - 45.5%), and metronidazole (1.8%, 0 - 20.0%), all with wide variation between countries.ConclusionConsidering that the mean resistance rates across Europe were higher than expected for three of the four anti-anaerobic antibiotics under surveillance, both local AST of clinically relevant isolates of Bacteroides fragilis and continued surveillance on an international level is warranted.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Klinisk laboratoriemedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Clinical Laboratory Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Microbiology in the medical area (hsv//eng)

Keyword

Antimicrobial resistance surveillance
Resistance rate
Bacteroides fragilis
Anaerobic bacteraemia
invasive isolates
Bloodstream infection

Publication and Content Type

art (subject category)
ref (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view